| Description | 1. Tetrahydrocoptisine (STYLOPINE) has effective effects in suppressing inflammation. 2. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process. 3. Tetrahydrocoptisine has gastroprotective activity, is attributed to reducing NO production and adjusting the pro-inflammatory cytokine, inhibited neutrophil accumulation and NF-κB expression. 4. Tetrahydrocoptisine is an active anti-inflammatory constituent by inhibition of TNF-α, IL-6 and NO production possibly via down-regulation of NF-κB activation, phospho-ERK1/2 and phospho-p38MAPK signal pathways. |
| Synonyms | 人血草碱, STYLOPINE |
| molecular weight | 323.34 |
| Molecular formula | C19H17NO4 |
| CAS | 4312-32-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble DMSO: 4.17 mg/mL (12.89 mM), Sonication is recommended. |
| References | 1. Li W , Huang H , Niu X , et al. Tetrahydrocoptisine Protects Rats from LPS-Induced Acute Lung Injury[J]. Inflammation, 2014, 37(6):2106-2115. |